Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Evofem Biosciences Inc (EVFM)  
$1.00 0.00 (0.00%) as of 4:30 Thu 6/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 35,380,000
Market Cap: 35.38(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1 - $1.25
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Evofem Biosciences is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health, including woman-controlled contraception and protection from certain sexually transmitted infections. Co.'s commercial product, Phexxi, is the U.S. Food and Drug Administration (FDA)-approved, hormone-free, woman-controlled, prescription contraceptive gel for women. Co. is evaluating Phexxi for two potential new indications: the prevention of chlamydia and the prevention of gonorrhea in women. The FDA has designated Phexxi, using the investigational name EVO100, as a Qualified Infectious Disease Product.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 141,000
Total Buy Value $0 $0 $0 $49,703
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 114 114 114
Total Sell Value $0 $10 $10 $10
Total People Sold 0 2 2 2
Total Sell Transactions 0 2 2 2
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 194
  Page 2 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Culwell Kelly Chief Medical Officer   •       –      –    2021-05-20 4 D $0.86 $36,172 D/D (42,061) 273,390     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2021-05-20 4 D $0.86 $90,558 D/D (105,300) 800,837     -
   File Justin J. Chief Financial Officer   •       –      –    2021-05-20 4 D $0.86 $36,361 D/D (42,280) 415,888     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2021-03-09 4 AB $2.28 $103,168 D/D 45,249 906,137     -
   File Justin J. Chief Financial Officer   •       –      –    2021-02-03 4 A $0.00 $0 D/D 200,000 458,168     -
   Barrans Russell Chief Commercial Officer   •       –      –    2021-02-03 4 A $0.00 $0 D/D 200,000 481,852     -
   Culwell Kelly Chief Medical Officer   •       –      –    2021-02-03 4 A $0.00 $0 D/D 200,000 315,451     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2021-02-03 4 A $0.00 $0 D/D 200,000 343,542     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2021-02-03 4 A $0.00 $0 D/D 500,000 860,888     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2020-11-17 4 B $2.20 $19,998 D/D 9,090 143,542 2.74     -
   File Justin J. Chief Financial Officer   •       –      –    2020-11-17 4 B $2.17 $16,839 D/D 7,760 258,168 2.74     -
   Barrans Russell Chief Commercial Officer   •       –      –    2020-09-11 4 B $2.08 $6,240 D/D 3,000 279,052 2.74     -
   Barrans Russell Chief Commercial Officer   •       –      –    2020-09-10 4 B $2.71 $2,710 D/D 1,000 276,052 2.66     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2020-09-08 4 S $3.26 $399,350 D/D (122,500) 360,888     -
   Barrans Russell Chief Commercial Officer   •       –      –    2020-07-08 4 D $3.30 $67,257 D/D (20,381) 275,052     -
   Rarick Lisa Dale Director   –       •      –    2020-06-17 4 B $2.99 $15,698 D/D 5,250 5,250 2.39     -
   Hall William Walmsley Director   –       •      –    2020-06-15 4 B $2.85 $14,250 D/D 5,000 5,000 2.39     -
   Kamdar Kim P. Director   –       •       •   2020-06-12 4 B $2.94 $14,700 D/D 5,000 9,287 3.92     -
   File Justin J. Chief Financial Officer   •       –      –    2020-06-12 4 B $3.14 $26,690 D/D 8,500 250,408 2.74     -
   Invesco Ltd. 10% Owner   –       –       •   2020-06-05 4 B $3.50 $3,000,001 I/I 857,143 13,226,532 1.5     -
   Barrans Russell Chief Commercial Officer   •       –      –    2020-06-05 4 D $3.31 $51,156 D/D (15,455) 293,509     -
   Culwell Kelly Chief Medical Officer   •       –      –    2020-06-05 4 D $3.31 $104,424 D/D (31,548) 115,451     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2020-06-05 4 D $3.31 $104,563 D/D (31,590) 134,452     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2020-06-05 4 D $3.31 $283,402 D/D (85,620) 479,085     -
   File Justin J. Chief Financial Officer   •       –      –    2020-06-05 4 D $3.31 $141,701 D/D (42,810) 237,605     -
  194 Records found
  1  2  3  4  5  6  7  8   
  Page 2 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us